Revive Therapeutics Ltd (RVVTF)

[ReviveThomas]

Are you referring to this article: https://www.biospace.com/article/releases/revive-therapeutics-partners-with-supriya-to-pursue-eua-for-bucillamine-to-treat-covid-in-india/

“While our Phase 3 clinical study for COVID-19 is ongoing in the USA, we are laying the ground work by partnering with Supriya to execute on our global manufacturing and commercialization plans and leveraging their regulatory expertise and commercial reach with 78 countries they currently supply pharmaceutical products to,” said Michael Frank, CEO of Revive. “We are focused on completing our current Phase 3 study in the USA and also obtaining EUA. These results will support drug approval registrations globally, including India, Europe, and Canada.”